Evidence map›Paper›PMID 39090322›Full record

ArticleArchives of virology2024

Infection with bovine leukemia virus belonging to group A or B-1 contributes more strongly to the development of enzootic bovine leukosis in young cattle than the presence of bovine lymphocyte antigen-DRB3 susceptibility alleles.

Yuki Fujii, Masaki Maezawa, Masataka Akagami, Junko Kawakami, Yuri Fujimoto, Hisashi Inokuma

Abstract read
In one paragraph

Article in Archives of virology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yuki FujiiLivestock Division, Ibaraki Prefecture Government, Mito, Ibaraki, 310-8555, Japan.
Masaki MaezawaLaboratory of OSG Veterinary Science for Global Disease Management, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Bunkyo-ku, Tokyo, 113-8657, Japan. amaezawa@g.ecc.u-tokyo.ac.jp.ORCID http://orcid.org/0000-0003-2483-4168
Masataka AkagamiIbaraki Prefectural Kensei Livestock Hygiene Service Center, Chikusei, Ibaraki, 300-4516, Japan.
Junko KawakamiIbaraki Prefectural Kensei Livestock Hygiene Service Center, Chikusei, Ibaraki, 300-4516, Japan.
Yuri FujimotoLaboratory of OSG Veterinary Science for Global Disease Management, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Bunkyo-ku, Tokyo, 113-8657, Japan.
Hisashi InokumaLaboratory of OSG Veterinary Science for Global Disease Management, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Bunkyo-ku, Tokyo, 113-8657, Japan.ORCID http://orcid.org/0000-0003-1124-3094

Funding

Ito Foundation 21Japan Society for the Promotion of Science London 23H02378Japan Society for the Promotion of Science London 23K14077
6 · The paper itself

Abstract

In this study, we compared the effects of different bovine leukemia virus (BLV) strains and bovine lymphocyte antigen (BoLA)-DRB3 alleles in cattle with enzootic bovine leukosis (EBL) aged either <3 years or ≥3 years. The frequency of infection with BLV belonging to group A or B-1 in cattle aged <3 years with EBL was significantly higher than that in cattle aged ≥3 years, regardless of which BoLA-DRB3 allele was present. This suggests that infection with group A or B-1 BLV contributes more strongly to the development of EBL in young cattle than the presence of early-EBL-onset susceptibility BoLA-DRB3 alleles.

Indexed as

AllelesEnzootic Bovine LeukosisGenetic Predisposition to DiseaseLeukemia Virus, BovineAnimalsCattleHistocompatibility Antigens Class IIBoLA-DRB3 antigenHistocompatibility Antigens Class II

Identifiers

PMID39090322
PMCPMC11294373

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.